Access the full text.
Sign up today, get DeepDyve free for 14 days.
PURPOSE: Head and Neck squamous cell carcinomas show an increasing incidence and make up to 5% of all malignancies. In this work three cell surface proteins are investigated, which could be possible targets in currently arising tailored cancer treatment: Epithelial cell adhesion molecule (EpCam), the epidermal growth factor receptor (EGFR, c-erbB-1 or HER1) and HER2/neu (c-erbB-2). MATERIALS AND METHODS: In this study, specimens from 114 histologically verified squamous cell carcinoma of pharynx and oral cavity were analysed. The surface proteins were tested with pharmacodiagnostic kits. RESULTS: With 44.7% (51/114) EGFR was found to be overexpressed most frequently in this cohort. A usable distribution for EpCam and nearly lacking of HER2 was shown in 22.8% (26/114) and 3.5 % (4/114), respectively. CONCLUSION: These data show that EGFR and EpCam might have a relevant role for the biology of this disease. Its relevance for a therapeutic application cannot yet be concluded.
memo - Magazine of European Medical Oncology – Springer Journals
Published: Jan 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.